Biphenomycins, natural products derived from bacteria, show excellent antimicrobial activity, but have long remained out of ...

Following today's meeting with the FDA concerning IBT's live biotherapeutic product, IBT has decided to pursue an accelerated approval pathway for IBP-9414. The FDA's Accelerated Approval Program allo ...

Bacteria that produce many antibiotics use a surprising self-poisoning system to coordinate development. Sensing a key signal triggers a pathway creating toxic byproducts, but only those bacteria able ...

Synergy graph illustrating the efficacy of the dual inhibition Mtb treatment strategy. (Credit: Campbell lab) Tuberculosis is both curable and ...

An international research team has uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a ...

New research suggests habitual nose picking could damage the nasal lining, allowing bacteria to enter the brain via the ...

A disease that has stalked humanity for millennia may have finally met its match. Mycobacterium tuberculosis, the pathogen ...

A research team has identified a significant environmental risk linked to the decline of submerged macrophytes: the ...

A Swediah biopharma company developing live biotherapeutic products for diseases affecting premature infants, led by IBP-9414 ...

In several disease conditions, including infections and cancers, innate immune activation and nutrient scarcity occur ...

The PrIMAVeRa project develops a platform to evaluate how mAbs can combat AMR by reducing antibiotic use and providing ...